Heron Therapeutics Launches Private Equity Strategy to Enhance Investment Opportunities for Accredited Investors

Heron Therapeutics Expands Investment Horizons with New Private Equity Strategy

Heron Therapeutics announces the launch of a new private equity strategy aimed at providing accredited investors and family offices with streamlined access to a diversified global portfolio of over 7,000 private companies. This initiative, unveiled on December 9, 2025, marks a significant expansion of Heron’s alternative investments platform, which previously focused primarily on private credit offerings. By introducing this strategy, Heron enhances its commitment to making institutional-grade private market assets accessible to individual investors. The strategy is designed for long-term capital appreciation and provides an alternative to the income-oriented approach of its existing private credit investments.

The new private equity strategy features four seasoned fund managers with over 30 years of experience in managing private equity funds. These managers have collectively achieved an impressive average annualized return of 13.2% since inception, even after deducting a 1% management fee. This focus on experienced management is intended to instill confidence in investors as they venture into the private equity space, which is increasingly recognized for its potential for higher returns compared to traditional public equities. CEO Mike Sall emphasizes that this launch aligns with Heron’s broader mission of democratizing access to high-quality investment opportunities, catering to a growing demographic of accredited investors seeking diversification in their portfolios.

To facilitate a seamless investing experience, Heron implements features such as low minimum investment thresholds, a fully digital platform, consolidated tax reporting, and monthly subscription options. Notably, the private equity strategy imposes no multi-year lockups or capital calls, making it an attractive option for individual investors who may be hesitant to commit large sums for extended periods. With the private equity market surpassing $9 trillion and institutional investors allocating nearly 17% of their portfolios to this asset class, Heron’s strategic entry into private equity positions the company to respond to a growing demand for diversified investment options that are less correlated with traditional market fluctuations.

In addition to this new private equity offering, Heron continues to build its reputation in the alternative investment sector. The firm's approach aims to provide tailored solutions that meet the evolving needs of investors in a rapidly changing financial landscape. As the appeal of private equity grows, Heron remains focused on enhancing its value proposition by ensuring that individual investors have access to high-quality, institutional-grade investment opportunities. This move reflects a broader trend in the investment community, where the quest for yield and diversification is becoming increasingly critical.